DCIS-Mi also appears to have a more aggressive biological phenotype with a greater tendency toward larger lesion size, axillary LN metastases, higher grade, comedo necrosis, ER-negativity, PR-negativity, and HER2-positivity. Here, ERBB2 is linked to ductal breast carcinoma in situ.